Summit Therapeutics
Robert Normandia, MD, currently serves as the Regional Medical Scientific Director for East Coast Thoracic Oncology at Summit Therapeutics, Inc., starting in March 2024. Prior to this, Robert held a position in Medical Affairs Oncology at AstraZeneca from 2019 to April 2024, focusing on thoracic oncology and liquid tumor diagnostics. Experience also includes roles at Merck KGaA in Immuno-Oncology, where support extended to various malignancies, and at Boehringer Ingelheim as Director of Health Science Executives in the Cardiovascular/Metabolic Division. Robert's earlier career involved clinical affairs at Endo Pharmaceuticals, recruiting for trials at GTx Biotech, and serving as a Medical Science Liaison at ICOS, with a foundation in medicine from UAG and undergraduate degrees from Manhattan University.
This person is not in any teams
This person is not in any offices